Renflexis Prices, Coupons, Copay Cards & Patient Assistance
Renflexis (infliximab) is a member of the TNF alfa inhibitors drug class and is commonly used for Ankylosing Spondylitis, Crohn's Disease, Crohn's Disease - Active, and others.
Renflexis prices
Intravenous Powder For Injection
abda 100 mg Renflexis intravenous powder for injection from $814.26 for 1 powder for injection
| Quantity | Per unit | Price |
|---|---|---|
| 1 | $814.26 | $814.26 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Get your FREE Drugs.com Discount Card
Save up to 80% off the cost of prescription drugs and OTC medicines valid at over 65,000 pharmacies.
This is a drug discount program, not an insurance plan.
Renflexis Coupons, Copay Cards and Rebates
Renflexis offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.
Renflexis Organon Co-Pay Assistance Program
Eligible commercially insured patients pay $5 per infusion with savings of up to $20,000 per calendar year.
- Applies to:
- Renflexis
- Number of uses:
- Per prescription per calendar year
Form more information phone: 866-847-3539 or Visit website
Patient Assistance & Copay Programs for Renflexis
Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.
Provider: Patient Access Network Foundation (PAN)
Eligibility requirements:- *See Additional Information section below
- Between 400-500% of FPL
- FDA Approved Diagnosis - See Program Website for Details
- Must reside and receive treatment in US
- *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
- Renflexis (infliximab-ABDA) Injection; IV
More information please phone: 866-316-7263 Visit website
Provider: Organon Access Program: Renflexis
Eligibility requirements:- Determined case by case
- Not disclosed
- Medically appropriate condition/diagnosis
- Must be residing in the US or a US territory, and under the care of a US physician
- Patient must sign the enrollment form to give the program permission to access their financial information in order to determine eligibility. Patients in need who appear not to qualify should still call. Co-payment assistance, reimbursement support, and patient assistance programs are available for eligible patients.
- Renflexis (infliximab-abda) Injection; IV
More information please phone: 866-847-3539 Visit website
Provider: Organon Pro
Eligibility requirements:- Determined case by case
- Not disclosed
- Medically Necessary as determined by a Doctor
- Must be treated by US licensed healthcare provider
- Resources for HEALTHCARE PROFESSIONALS ONLY. The Physician must register to access tools and materials for patient support, product sample requests, and up-to-date professional resources.
- Renflexis (infliximab-abda) Injection; IV
More information please phone: 844-674-3200 Visit website
Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.
See also:
Otezla
Otezla (apremilast) is used to treat plaque psoriasis, psoriatic arthritis, and oral ulcers ...
Skyrizi
Skyrizi (risankizumab) is used to treat plaque psoriasis, psoriatic arthritis, ulcerative colitis ...
Entyvio
Entyvio (vedolizumab) is used to treat ulcerative colitis (UC) and Crohn's disease, reducing ...
Omvoh
Omvoh is used to treat moderate to severe ulcerative colitis or Crohn's disease in adults. This ...
Stelara
Stelara (ustekinumab) is used to treat Crohn's disease, ulcerative colitis, plaque psoriasis, and ...
Cosentyx
Cosentyx (secukinumab) is used to treat plaque psoriasis, psoriatic arthritis, ankylosing ...
Humira
Humira is a tumor necrosis factor blocker used to treat many inflammatory conditions in adults ...
Ilumya
Ilumya (tildrakizumab) is used to treat moderate-to-severe plaque psoriasis to reduce plaques ...
Taltz
Taltz (ixekizumab) is used to treat plaque psoriasis, psoriatic arthritis, and ankylosing ...
More about Renflexis (infliximab)
- Check interactions
- Compare alternatives
- Reviews (8)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: TNF alfa inhibitors
- Breastfeeding
- En español
Patient resources
- Renflexis drug information
- Renflexis (Infliximab Intravenous) (Advanced Reading)
- Renflexis (Infliximab-abda Intravenous) (Advanced Reading)
Other brands
Remicade, Inflectra, Avsola, Zymfentra, Ixifi
Professional resources
Other brands
Remicade, Inflectra, Avsola, Zymfentra